XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.20.2

Shareholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2020
Stockholders Equity Note [Abstract] |
Shareholders' Equity | NOTE 14 – Shareholders’ Equity Share count and par value data related to shareholders’ equity are as follows:
|  | As of |
|  | September 30, |  |  | December 31, |
|  | 2020 |  |  | 2019 |
Preferred Stock |  |  |  |  |  |  |  |
Par value per share |  | No par value |  |  | No par value |
Shares authorized |  |  | 25,000,000 |  |  |  | 25,000,000 |
Shares outstanding |  |  | — |  |  |  | — |
Common Stock |  |  |  |  |  |  |  |
Par value per share |  | No par value |  |  | No par value |
Shares authorized |  |  | 75,000,000 |  |  |  | 75,000,000 |
Shares issued |  |  | 57,067,574 |  |  |  | 56,929,298 |
Shares outstanding |  |  | 32,267,951 |  |  |  | 32,472,406 |
Treasury stock |  |  |  |  |  |  |  |
Shares held |  |  | 24,799,623 |  |  |  | 24,456,892 |
On February 7, 2019, the Board of Directors authorized a new stock repurchase program with a maximum dollar limit of $25,000 in stock repurchases, which replaced the previous program. During the nine months ended September 30, 2020 and 2019, 342,731 and 286,726 shares of common stock were repurchased for $8,080 and $8,045, respectively. Approximately $5,740 is available for future purchases. A roll-forward of common shares outstanding is as follows:
|  | Nine months ended |
|  | September 30, |  |  | September 30, |
|  | 2020 |  |  | 2019 |
Balance at the beginning of the year |  |  | 32,472,406 |  |  |  | 32,750,727 |
Repurchases |  |  | (342,731 | ) |  |  | (286,726 | )
Restricted share issuances |  |  | 138,276 |  |  |  | 137,888 |
Balance at the end of the period |  |  | 32,267,951 |  |  |  | 32,601,889 |
Certain potentially dilutive restricted stock units are excluded from diluted earnings per share because they are anti-dilutive. The number of outstanding awards that were anti-dilutive for the nine months ended September 30, 2020 and 2019 were 68,198 and 20,273, respectively. There were no anti-dilutive awards outstanding for the three months ended September 30, 2020 and the three months ended September 30, 2019.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration